Core Viewpoint - The company, Kang En Bei, is actively expanding its international business, particularly in the field of anti-infection raw materials and traditional Chinese medicine formulations, achieving competitive advantages and making significant progress in international registrations and exports [1] Group 1: International Business Expansion - The company sells products to multiple countries, including Italy and Germany within the EU [1] - The company has developed a competitive advantage in the internationalization of anti-infection raw materials after years of effort [1] - The company is actively expanding its traditional Chinese medicine formulation business internationally [1] Group 2: Product Registration and Export - The company has completed international registrations for several products, including Plurolan tablets/capsules, Chuanlian Ning tablets, Jixuegan cream, and Fengyoujing [1] - Ginkgo biloba extract has obtained the CEP certificate from EDQM, and related products have begun export sales [1] - The company plans to adjust product forms to expand into different international markets [1]

Core Viewpoint - The company emphasizes the importance of expanding its international business, particularly in the field of active pharmaceutical ingredients (APIs) for anti-infection products and traditional Chinese medicine formulations [1] Group 1: International Business Expansion - The company has developed a competitive advantage in the internationalization of APIs in the anti-infection sector after years of effort [1] - The company is actively expanding its international market for traditional Chinese medicine formulations [1] Group 2: Product Registration and Certification - The company has completed international registrations for several products, including Plavix tablets/capsules, Intestinal Tract Ning tablets, Jixuegan ointment, and Fengyoujing [1] - Ginkgo biloba extract has obtained the CEP certificate from EDQM, and related products have begun to be exported [1] Group 3: Market Strategy - The company plans to adjust product forms for different markets and leverage national strategies and policy support, such as the "Belt and Road" initiative, to expand its international market [1]

Core Viewpoint - The company emphasizes the importance of expanding its international business, particularly in the field of active pharmaceutical ingredients (APIs) for anti-infection products and traditional Chinese medicine formulations [1] Group 1: International Business Expansion - The company has developed a competitive advantage in the internationalization of APIs in the anti-infection sector after years of effort [1] - The company is actively expanding its international market for traditional Chinese medicine formulations [1] Group 2: Product Registration and Certification - The company has completed international registrations for several products, including Plavix tablets/capsules, Intestinal Tract Ning tablets, Jixuegan ointment, and Fengyoujing [1] - Ginkgo biloba extract has obtained the CEP certificate from EDQM, and related products have begun exporting [1] Group 3: Market Strategy - The company plans to adjust product forms for different markets and leverage national strategies and policy support, such as the Belt and Road Initiative, to expand its international market [1]

Core Viewpoint - The company, Morning Light Bio (300138), is focusing on developing a tiered product strategy, with significant growth potential in its sweetener product, stevia, which has a larger market space compared to other products like chili red and chili extract [1] Group 1: Product Strategy - The company has identified several key products in its tiered strategy, including stevia, ginkgo leaf extract, sophora flower extract, inulin, and essential oils, aiming to establish them as major products in the market [1] - The market share of stevia has been steadily increasing, indicating a growing revenue stream for the company [1] - The company is leveraging its technological advantages to enhance industry efficiency and promote overall industry development, even for products with currently smaller market sizes [1] Group 2: Long-term Goals - The long-term objective of the company is to transform its tiered products into new major products, suggesting a larger growth potential compared to its main products [1]